Charalampos S. Floudas

Matching patients to clinical trials with large language models

Qiao Jin, Zifeng Wang, Charalampos S. Floudas et al. · Nature Communications · 2024 · 154 citations · Full text

Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer

Changqing Xie, Austin G. Duffy, Donna Mabry‐Hrones et al. · Hepatology · 2018 · 99 citations · Full text

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

Marijo Bilušić, Sheri McMahon, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 59 citations · Full text

Combined immune checkpoint inhibition (ICI) with tremelimumab and durvalumab in patients with advanced hepatocellular carcinoma (HCC) or biliary tract carcinomas (BTC).

Charalampos S. Floudas, Changqing Xie, Gagandeep Brar et al. · Journal of Clinical Oncology · 2019 · 43 citations

Immunology, Pharmacotherapy, Immune Cell Therapy +24

A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer

Charalampos S. Floudas, Gagandeep Brar, Donna Mabry‐Hrones et al. · Clinical Colorectal Cancer · 2019 · 42 citations · Full text